Review: A review of mechanisms of contrast for diffuse optical imaging of cancer

Journal of Near Infrared Spectroscopy

Volumn 20, Issue 1, 2012, Pages 185-202

  Enfield, Louise C ^a   Gibson, Adam P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Cancer biology; Characteristics of cancer; Contrast mechanisms; Endogenous contrast; Exogenous contrast; NIR imaging; NIR spectroscopy

Indexed keywords

EID: 84859092078     PISSN: 09670335     EISSN: None     Source Type: Journal    
DOI: 10.1255/jnirs.949     Document Type: Review

References (140)

1. R.A. Weinberg, The Biology of Cancer. Garland Science, Taylor and Francis Group, New York City, USA (2007).
2. R.J.B. King and M.W. Robins, Cancer Biology, 3rd Edn. Prentice Hall, London, UK (2006).
3. L. Pecorino, Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics, 2nd Edn. OUP, Oxford, UK, (2008).
4. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward and D. Forman, "Global cancer statistics", CA 61, 69 (2011).
5. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers and D.M. Parkin, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008", Int. J. Cancer 127, 2893(2010), doi:10.1002/ijc.25516
6. B. Rachet, L.M. Woods, E. Mitry, M. Riga, C. Cooper, M.J. Quinn, J.A. Steward, H. Brenner, J. Estève, R. Sullivan and M.P. Coleman, "Cancer survival in England and Wales at the end of the 20th century", Br. J. Cancer 99, 2 (2008). doi:10.1038/sj.bjc.6604571
7. J.L. Ambrus, C.M. Ambrus, I.B. Mink and J.W. Pickren, "Causes of death in cancer patients", J. Med. 6, 61 (1975).
8. S.K. Kim and G.D. Demetri, "Chemotherapy and neutropenia", Hematol. Oncol. Clin. North Am. 10, 377 (1996). doi:10.1016/S0889-8588 (05) 70344-0
9. D. Hanahan and R.A. Weinberg, "The hallmarks of cancer", Cell 100, 57 (2000). doi:10.1016/S0092-8674 (00) 81683-9
10. D. Hanahan and R.A. Weinberg, "Hallmarks of cancer: The next generation", Cell 144, 646 (2011). doi:10.1016/j.cell.2011.02.013
11. V. Kumar, A.K. Abbas, N. Fausto and J. Aster, Robbins and Cotran Pathologic Basis of Disease, 8th Edn. Saunders, Elsevier, Philadelphia, USA (2009).
12. A.T. Chan, S. Ogino and C.S. Fuchs, "Aspirin and the risk of colorectal cancer in relation to the expression of COX-2", N. Engl. J. Med. 356, 2131 (2007). doi:10.1056/NEJMoa067208 (Pubitemid 47010839)
13. M. López-Lázaro, "The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?" Anticancer Agents Med. Chem. 8, 305 (2008). doi:10.2174/187152008783961932 (Pubitemid 351761435)
14. M.G. Vander Heiden, L.C. Cantley and C.B. Thompson "Understanding the Warburg effect: The metabolic requirements of cell proliferation", Science 324, 1029 (2009). doi:10.1126/science.1160809
15. A.E. Cerussi, A.J. Berger, F. Bevilacqua, N. Shah, D. Jakubowski, J. Butler, R.F. Holcombe and B.J. Tromberg, "Sources of absorption and scattering contrast for near infrared optical mammography", Acad. Radiol. 8, 211 (2001). doi:10.1016/S1076-6332 (03) 80529-9
16. S.B. Colak, M.B. van der Mark, G.W. Hooft, J.H. Hoogenraad, E.S. van der Linden and F.A. Kuijper, "Clinical optical tomography and NIR spectroscopy for breast cancer detection", IEEE Quantum Electronics 5, 1143 (1999). doi:10.1109/2944.796341 (Pubitemid 30544916)
17. V.G. Peters, D.R. Wyman, M.S. Patterson and G.L. Frank, "Optical properties of normal and diseased human breast tissue in the visible and near infrared", Phys. Med. Biol. 35, 1317 (1990). doi:10.1088/0031-9155/35/9/010
18. X. Cheng, J. Mao, R. Bush, D.B. Kopans, R.H. Moore and M. Chorlton, "Breast cancer detection by mapping hemoglobin concentration and oxygen saturation", Appl. Opt. 42, 6412 (2003). doi:10.1364/AO.42.006412
19. S. Jiang, B.W. Pogue, T.O. McBride and K.D. Paulsen, "Quantative analysis of near-infrared tomography: sensitivity to the tissue-simulating pre calibration phantom", J. Biomed. Opt. 8, 308 (2003). doi:10.1117/1.1559692
20. S. Srinivasan, B.W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J.J. Gibson, T.D. Tosteson, S.P. Poplack and K.D. Paulsen, "Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared tomography", Proc. Nat. Acad. Sci USA 100, 12349 (2003). doi:10.1073/pnas.2032822100 (Pubitemid 37271563)
21. J. Folkman, "Tumor angiogenesis: therapeutic implications", N. Engl. J. Med. 285, 1182 (1971). doi:10.1056/NEJM197111182852108
22. Y. Boucher, M. Leunig and R.K. Jain, "Tumor angiogenesis and interstitial hypertension", Cancer Res. 56, 4264 (1996).
23. D.M. McDonald and P. Baluk, "Significance of blood vessel leakiness in cancer", Cancer Res. 6, 5381 (2002).
24. P. Vaupel, F. Kallinowski and P. Okunieff, "Blood fow, oxygen and nutrient supply, and metabolic environment of human tumors: a review", Cancer Res. 49, 6449 (1989).
25. J. Folkman, "Angiogenesis", Annu. Rev. Med. 57, 1 (2006). doi:10.1146/annurev. med.57.121304.131306
26. J. Folkman, "Tumor angiogenesis: therapeutic implications", N. Engl J. Med. 285, 1182 (1971). doi:10.1056/NEJM197111182852108
27. J. Folkman, "Angiogenesis and apoptosis", Semin. Cancer Biol. 13, 159 (2003). doi:10.1016/S1044-579X (02) 00133-5
28. D. Liao and R.S. Johnson, "Hypoxia-A key regulator of angiogenesis in cancer", Cancer Metastasis Rev. 26, 290 (2007). doi:10.1007/s10555-007- 9066-y (Pubitemid 47101669)
29. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts and P. Walte, Molecular Biology of the Cell, 5th Edn. Garland Science, Taylor and Francis Group, New York, USA (2008).
30. G. Bergers and L.E. Benjamin, "Tumorigenesis and the angiogenic switch", Nature Rev. Cancer 3, 401 (2003). doi:10.1038/nrc1093 (Pubitemid 37328844)
31. D.A. Chan and A.J. Giaccia, "Hypoxia, gene expression and metastasis", Cancer Metastasis Rev. 26, 333 (2007). doi:10.1007/s10555-007- 9063-1 (Pubitemid 47101666)
32. A. Makris, T.J. Powles, S. Kakolyris, M. Dowsett, S.E. Ashley and A.L. Harris, "Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma", Cancer 85, 1996 (1999). doi:10.1002/9SICI) 1097-0142 (19990501) 85:9<1996::AID-CNCR17>3.0. CO;2-H
33. D.R. Leff, O. Warren, L.C. Enfield, A.P. Gibson, T. Athanasiou, D.K. Pattern, J.C. Hebden, G.Z. Yang and A. Darzi, "Diffuse optical imaging of the healthy and diseased breast-a systematic review", Breast Cancer Res. Treat. 108, 9 (2008). doi:10.1007/s10549-007-9582-z (Pubitemid 351623242)
34. L.C. Enfield, A.P. Gibson, J.C. Hebden and M. Douek, "Optical tomography of breast cancer-monitoring response to primary medical therapy", Targeted Oncol. 4, 219 (2009). doi:10.1007/s11523-009-0115-z
35. C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B.J. Tromberg and A.G. Yodh, "Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy", J. Biomed. Opt. 12, 051903 (2007). doi:10.1117/1.2798595 (Pubitemid 351309606)
36. S. Jiang, B.W. Pogue, C.M. Carpenter, S.P. Poplack, W.A. Wells, C.A. Kogel, J.A. Forero, L.S. Muffy, G.N. Schwartz, K.D. Paulsen and P.A. Kaufman, "Evaluation of breast tumor response to neo adjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes", Radiology 252, 551 (2009). doi:10.1148/radiol.2522081202
37. V.T.C. Chang, P.S. Cartwright, S.M. Bean, G.M. Palmer, R. Bentley and N. Ramanujam, "Quantitative physiology of the precancerous cervix in vivo though optical spectroscopy", Neoplasia 11, 325 (2009).
38. B.W. Pogue, S.P. Poplack, T.O. McBride, W.A. Wells, K.S. Osterman, U.L. Osterberg and K.D. Paulsen, "Quantitative haemoglobin tomography with diffuse near-infrared spectroscopy: Pilot results in the breast", Radiology 218, 261 (2001).
39. Q. Zhu, S.H. Kurtzma, O. Hedge, S. Tannenbaum, M. Kane, M. Huang, N.G. Chen, B. Jagjivan and K. Zarfos "Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers", Neoplasia 7, 263 (2005). doi:10.1593/neo.04526 (Pubitemid 40411638)
40. M. Krag, B. Quistorff, E.L. Lund and P.E.G. Kristjansen, "Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy", Neoplasia 3, 324 (2001). doi:10.1038/sj.neo. 7900164 (Pubitemid 32801882)
41. M.G. Pakalniskis, W.A. Wells, M.C. Schwab, H.M. Froehlich, S. Jiang, Z. Li, T.D. Tosteson, S.P. Poplack, P.A. Kaufman, B.W. Pogue and K.D. Paulsen, "Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer?", Radiology 259, 365 (2011). doi:10.1148/radiol.11100699
42. J. Laufer, P. Johnson, E. Zhang, B. Treeby, B. Cox, B. Pedley and P. Beard, "In vivo longitudinal photoacoustic imaging of subcutaneous tumours in mice", Proc. SPIE 7899, paper 789915 (2011).
43. H.F. Zhang, K. Maslov, G. Stoica and L.V. Wang "Functional photoacoustic microscopy for highresolution and non-invasive in vivo imaging", Nature Biotechnol. 24, 848 (2006). doi:10.1038/nbt1220 (Pubitemid 44086627)
44. J. Jose, S. Manohar, R.G.M. Kolkman, W. Steenbergen and T.G. van Leeuwen, "Imaging of tumor vasculature using Twente photoacoustic systems", J. Biophotonics 2, 701 (2009). doi:10.1002/jbio.200910025
45. R.A. Kruger, R.B. Lam, D.R. Reinecke, S.P. del Rio and R.P. Doyle "Photoacoustic angiography of the breast", Med. Phys. 37, 6096 (2010). doi:10.1118/1.3497677
46. P. Vaupel and A. Mayer, "Hypoxia in cancer: significance and impact on clinical outcome", Cancer Metastasis Rev. 26, 225 (2007). doi:10.1007/s10555-007-9055-1 (Pubitemid 47101660)
47. P. Vaupel "Tumor microenvironmental physiology and its implications for radiation oncology", Semin. Radiat. Oncol. 14, 198 (2004). doi:10.1016/j.semradonc.2004.04.008 (Pubitemid 38903223)
48. P. Vaupel, S. Briest and M. Hockel, "Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications", WMW 152, 334 (2002). doi:10.1046/j.1563-258X.2002.02032.x (Pubitemid 34824207)
49. 2predicts survival in advanced cancer of the uterine cervix", Radiother. Oncol. 26, 45 (1993). doi:10.1016/0167-8140 (93) 90025-4
50. J.C. Mottram, "A factor of importance in the radiosensitivity of tumours", Br. J. Radiol. 9, 606 (1931). doi:10.1259/0007-1285-9-105-606
51. B.J. Moeller, R.A. Richardson and M.W. Dewhirst, "Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment", Cancer Metastasis Rev. 26, 241 (2007). doi:10.1007/s10555-007-9056-0 (Pubitemid 47101661)
52. D. Ewing "The oxygen fxation hypothesis: a reevaluation". Am. J. Clin. Oncol. 21, 355 (1998). doi:10.1097/00000421-199808000-00008 (Pubitemid 28366903)
53. P. Vaupel, A. Mayer and M. Hockel, "Tumor Hypoxia and malignant progression", Methods Enzymol. 381, 335 (2004). doi:10.1016/S0076-6879 (04) 81023-1
54. D.M. Brizel, S.P. Scully, J.M. Harrelson, L.J. Layfield, J.M. Bean, L.R. Prosnitz and M.W. Dewhurst, "Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma", Cancer Res. 56, 941 (1996).
55. 2 mapping", J. Biomed. Opt. 8, 53 (2003). doi:10.1117/1.1527049
56. P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli and R. Cubeddu, "Clinical trial of time-resolved scanning optical mammography at 4wavelengths between 683 and 975nm", J. Biomed. Opt. 9, 464 (2004). doi:10.1117/1.1695561
57. V. Ntziachristos, A.G. Yodh, M.D. Schnall and B. Chance, "MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions", Neoplasia 4, 347 (2002). doi:10.1038/sj.neo.7900244 (Pubitemid 34755845)
58. L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. Danesini and R. Cubeddu, "Characterization of female breast lesions from multi-wavelength time-resolved optical mammography", Phys. Med Biol. 50, 2489 (2005). doi:10.1088/0031-9155/50/11/004 (Pubitemid 40770635)
59. S. Srinivasan, B.W. Pogue, B. Brooksby, S. Jiang, H. Dehghani, C. Kogel, W.A. Wells, S.P. Poplack and K.D. Paulsen, "Near-infrared characterization of breast tumors in vivo using spectrally-constrained reconstruction", Technol. Cancer Res. Treat. 4, 513 (2005).
60. G.F. Lungu, M.-L. Li, X. Xie, L.V. Wang and G. Stoica, "In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion", Int. J. Oncol. 30, 45 (2007).
61. M.L. Li, J.T. Oh, X.Y. Xie, G. Ku, W. Wang, C. Li, G. Lungu, G. Stoica and L.V. Wang, "Simultaneous molecular and hypoxia imaging of brain tumors in vivo using spectroscopic photoacoustic tomography", Proc. IEEE 96, 481 (2008). doi:10.1109/JPROC.2007.913515
62. N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung and B. Tromberg, "Non-invasive functional optical spectroscopy of human breast tissue", Proc. Nat. Acad. Sci USA 98, 4420 (2001). doi:10.1073/pnas.071511098 (Pubitemid 32294992)
63. R. Gutmann, M. Leunig, J. Feyh, A.E. Goetz, K. Messmer, E. Kastenbauer and R.K. Jain, "Interstitial hypertension in head and neck tumors in patients: correlation with tumor size", Cancer Res. 52, 1993 (1992).
64. C.-H. Heldin, K. Rubin, K. Pietras and A. Östman, "High interstitial fluid pressure-an obstacle in cancer therapy", Nature Rev. Cancer 4, 806 (2004). doi:10.1038/nrc1456 (Pubitemid 39331152)
65. O. Tredan, C.M. Galmarini, K. Patel and I.F. Tannock, "Drug resistance and the solid tumor micro environment", JNCI 99, 144 (2007). doi:10.1093/jnci/djm135
66. Y. Boucher and R.K. Jain, "Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse", Cancer Res. 52, 5110 (1992).
67. Y. Boucher, H. Salehil, B. Witwerl, G.R. Harsh IV and R.K. Jain, "Interstitial fluid pressure in intracranial tumours inpatients and in rodents", Br. J. Cancer 75, 829 (1997). doi:10.1038/bjc.1997.148
68. T. Durduran, R. Choe, G. Yu, C. Zhou, J.C. Tchou, B.J. Czerniecki and A.G. Yodh, "Diffuse optical measurement of blood flow in breast tumors", Opt. Lett. 30, 2915 (2005). doi:10.1364/OL.30.002915 (Pubitemid 41654993)
69. C.H. Schmitz, D.P. Klemer, R. Hardin, M.S. Katz, Y. Pei, H.L. Graber, M.B. Levin, R.D. Levina, N.A. Franco, W.B. Solomon and R.L. Barbour, "Design and implementation of dynamic near-infrared optical tomograpic imaging instrumentation for simultaneous dual-breast measurements", Appl. Opt. 44, 2140 (2005). doi:10.1364/AO.44.002140 (Pubitemid 40567087)
70. S.A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans and D. Boas, "Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements", J. Biomed. Opt. 11, 064016 (2006). doi:10.1117/1.2397572 (Pubitemid 46323019)
71. S. Jiang, B.W. Pogue, A.M. Laughney, C.A. Kogel and K.D. Paulsen "Measurement of pressure-displacement kinetics of hemoglobin in normal breast tissue with near-infrared spectral imaging", Appl. Opt. 48, D130 (2009). doi:10.1364/AO.48.00D130
72. S. Suresh, "Biomechanics and biophysics of cancer cells", Acta Materialia 55, 3989 (2007). doi:10.1016/j.actamat.2007.04.022 (Pubitemid 46880462)
73. L. Hayfick "The limited in vitro lifetime of human diploid cell strains", Exp. Cell Res. 37, 614 (1965). doi:10.1016/0014-4827 (65) 90211-9
74. D. Zink, A.H. Fischer and J.A. Nickerson, "Nuclear structure in cancer cells", Nature Rev. Cancer 4, 677 (2004). doi:10.1038/nrc1430 (Pubitemid 39215066)
75. C. Li, S.R. Grobmyer, N. Massol, X. Liang, Q. Zhang, L. Chen, L.L. Fajardo and H. Jiang, "Non-invasive in vivo tomographic optical imaging of cellular morphology in the breast: Possible convergence of microscopic pathology and macroscopic radiology", Med. Phys. 35, 2493 (2008). doi:10.1118/1.2921129 (Pubitemid 351748657)
76. L.C. Enfield, A.P. Gibson, N.L. Everdell, D.T. Delpy, M. Schweiger, S.R. Arridge, C. Richardson, M. Keshtgar, M. Douek, and J.C. Hebden, "Three-dimensional time-resolved optical mammography of the uncompressed breast", Appl. Opt. 46, 3628 (2007). doi:10.1364/AO.46.003628 (Pubitemid 47184238)
77. D. Grosenick, H. Wabnitz, T.K. Moesta, J. Mucke, P.M. Schlag and H. Rinneberg, "Time-domain scanning optical mammography: II. Optical properties and tissue parameters of 87carcinomas", Phys. Med. Biol. 50, 2451 (2005). doi:10.1088/0031-9155/50/11/002 (Pubitemid 40770633)
78. L.B. Lovat, K. Johnson, G.D. Mackenzie, B.R. Clark, M.R. Novelli, S. Davies, M. O'Donovan, C. Selvasekar, S.M. Thorpe, D. Pickard, R. Fitzgerald, T. Fearn, I. Bigio and S.G. Bown, "Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus", Gut 55, 1078 (2006) doi:10.1136/gut.2005.081497 (Pubitemid 44085671)
79. A. Dhar, K.S. Johnson, M.R. Novelli, S.G. Bown, I.J. Bigio, L.B. Lovat and S.L. Bloom "Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique", Gastrointest. Endosc. 63, 257 (2006). doi:10.1016/j.gie.2005.07.026 (Pubitemid 43113194)
80. L. Qiu, D.K. Pleskow, R. Chuttani, E. Vitkin, J. Leyden, N. Ozden, S. Itani, L. Guo, A. Sacks, J.D. Goldsmith, M.D. Modell, E.B. Hanlon, I. Itzkan and L.T. Perelman "Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagus", Nat. Med. 16, 603 (2010). doi:10.1038/nm.2138
81. I.J. Bigio and S.G. Bown "Spectroscopic sensing of cancer and cancer chemotherapy, current status of translational research", Cancer Biol. Ther. 3, 259 (2004). doi:10.4161/cbt.3.3.694
82. H. Stein and J. Siewert, "Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management", Dysphagia 8, 276 (1993). doi:10.1007/BF01354551
83. N.J. Shaheen and J.E. Richter, "Barrett's oesophagus", Lancet 373, 850 (2009). doi:10.1016/S0140-6736 (09) 60487-6
84. J. Cameron, B.J. Ott and W.S. Payne, "The incidence of adenocarcinoma in columnar-lined Barrett's esophagus", N. Engl. J. Med. 313, 857 (1985). doi:10.1056/NEJM198510033131404
85. V.R. Kondepati, H.M. Heise and J. Backhaus "Recent application of near-infrared spectroscopy in cancer diagnosis and therapy", Anal. Bioanal. Chem. 390, 125 (2008). doi:10.1007/s00216-007-1651-y
86. N. Hirosawa, Y. Sakamoto, H. Katayama, S. Tonooka and K. Yano, "In vivo investigation of progressive alterations in rat mammary gland tumors by near-infrared spectroscopy", Anal. Biochem. 305, 156 (2002). doi:10.1006/abio.2002.5649 (Pubitemid 34666788)
87. S. Sinha, F.A. Lucas-Quesada, U. Sinha, N. de Bruhl and L.W. Bassett, "In vivo diffusion-weighted MRI of the breast: Potential for lesion characterization", J. Magn. Res. Imag. 15, 693 (2002). doi:10.1002/jmri. 10116 (Pubitemid 34606504)
88. S.H. Chung, A.E. Cerussi, C. Klifa, H.M. Baek, O. Birgul, G. Gulsen, S.I. Merritt, D. Hsiang and B.J. Tromberg, "In vivo water state measurements in breast cancer using broadband diffuse optical spectroscopy", Phys. Med. Biol. 53, 6713 (2008). doi:10.1088/0031-9155/53/23/005
89. A.E. Cerussi, N. Shah, D. Hsiang, A.J. Durkin, J. Butler and B.J. Tromberg, "In vivo sorption, scattering and physiological properties of 58malignant breast tumors determined by broadband diffuse optical spectroscopy", J. Biomed. Opt. 11, 044005 (2006). doi:10.1117/1.2337546 (Pubitemid 44803754)
90. C.M. Carpenter, B.W. Pogue, S. Jiang, H. Dehghani, X. Wang, K.D. Paulsen, W.A. Wells, J. Forero, C. Kogel, J.B. Weaver, S.P. Poplack and P.A. Kaufamn, "Image-guided optical spectroscopy provides molecular-specific information in vivo: MRI-guided spectroscopy of breast cancer haemoglobin, water and scatterer size", Opt. Lett. 32, 933 (2007). doi:10.1364/OL.32.000933 (Pubitemid 46449895)
91. J.H. Ali, W.B. Wang, M. Zevallos and R.R. Alfano, "Near infrared spectroscopy and imaging to probe differences in water content in normal and cancer human prostate tissues", Technol. Cancer Res. Treat. 3, 491 (2004).
92. C. Genestie, B. Zafrani, B. Asselain, A. Fourquet, S. Rozan, P. Validire, A. Vincent-Salomon and X. Sastre-Garau, "Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825cases of breast cancer: major importance of the mitotic count as a component of both grading systems", Anticancer Res. 18, 571 (1998).
93. S. Johansson, H. Svensson and J. Denekamp, "Dose response and latency for radiation-induced fbrosis, edema, and neuropathy in breast cancer patients", Int. J. Radiat. Oncol. 52, 1207 (2002). doi:10.1016/S0360-3016 (01) 02743-2
94. W. Tanamai, C. Chen, S. Siavoshi, A. Cerussi, D. Hsiang, J. Butler and B.J. Tromberg "Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study", J. Biomed. Opt. 14, 014024 (2009). doi:10.1117/1.3028012
95. J.C. Hebden, T.D. Yates, A. Gibson, N. Everdell, S.R. Arridge, D.W. Chicken, M. Douek and M.R.S. Keshtgar, "Monitoring recovery after laser surgery of the breast with optical tomography: a case study", App. Opt. 44, 1898 (2005). doi:10.1364/AO.44.001898 (Pubitemid 40479541)
96. F. Festy, S.M. Ameer-Beg, T. Ng and K. Suhling "Imaging proteins in vivo using fluorescence lifetime microscopy", Mol. BioSyst. 3, 381 (2007). doi:10.1039/b617204k (Pubitemid 46838787)
97. M.C. Skala, K.M. Riching, D.K. Bird, A. Gendron-Fitzpatrick, J. Eickhoff, K.W. Eliceiri, P.J. Keely and N. Ramanujam "In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia", J. Biomed. Opt. 12, 024014 (2007). doi:10.1117/1.2717503 (Pubitemid 46930496)
98. D. Sud, W. Zhong, D.G. Beer and M.-A. Mycek "Timeresolved optical imaging provides a molecular snapshot of altered metabolic function in living human cancer cell models", Optics Express, 14, 4412 (2006). doi:10.1364/OE.14.004412 (Pubitemid 43727631)
99. J.M. Maarek, D.P. Holschneider, J. Harimoto, J. Yang, O.U. Scremin and E.H. Rubinstein, "Measurement of cardiac output with indocyanine green transcutaneous fluorescence dilution technique", Anesthesiology 100, 1476 (2004). doi:10.1097/00000542-200406000-00020 (Pubitemid 38679317)
100. E. Keller, J. Froehlich, C. Muroi C.C. Sikorski and M. Muser "Neuromonitoring in intensive care: a new brain tissue probe for combined monitoring of intracranial pressure (ICP) cerebral blood flow (CBF) and oxygenation", Acta Neurochir. (Suppl.) 110, 217 (2011). doi:10.1007/978-3-7091-0356-2-39
101. M.L.J. Landsman, G. Kwant, G.A. Mook and W.G. Zijlstra, "Light-absorbing properties, stability, and spectral stabilization of indocyanine green", J. Appl. Physiol. 40, 575 (1976).
102. J.V. Frangioni, "New technologies for human cancer imaging", J. Clin. Oncol. 26, 4012 (2008). doi:10.1200/JCO.2007.14.3065
103. D.L. Morton, D.R. Wen, J.H. Wong, J.S. Economou, L.A. Cagle, F.K. Storm, L.J. Foshag and A.J. Cochran, "Technical details of intraoperative lymphatic mapping for early stage melanoma", Arch. Surg. 127, 392 (1992).
104. E.C. Hsueh, R.R. Turner and A.E. Giuliano, "Lymphoscintigraphy and lymphatic mapping for identification of sentinel lymph nodes", World J. Surg. 25, 794 (2001). doi:10.1007/s00268-001-0007-6 (Pubitemid 32531929)
105. G.H. Sakorafas and G. Peros, "Sentinel lymph node biopsy in breast cancer: what a physician should know, a decade after its introduction in clinical practice", Eur. J. Cancer Care 16, 318 (2007). doi:10.1111/j.1365-2354.2006.00762.x
106. J.C. Alex and D.N. Krag, "Gamma probe guided localization of lymph nodes", Surg. Oncol. 2, 137 (1993). doi:10.1016/0960-7404 (93) 90001-F
107. C. Cox, L. White, N. Allread, M. Meyers, D. Dickson, E. Dupont, A. Cantor, Q. Ly, S. Dessureault, J. KIng, S. Nicosia, V. Vrcel and N. Diaz, "Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy", Ann. Surg. Oncol. 13, 708 (2005). doi:10.1245/ASO.2006.05.017
108. C. Kim, K.H. Song and L.V. Wang, "Sentinel lymph node detection ex vivo using ultrasound modulated optical tomography", J. Biomed. Opt. 13, 020507 (2008). doi:10.1117/1.2907791
109. T. Kitao, T. Inomoto, M. Miwa and T. Shikayama, "Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer breast", Cancer 12, 211 (2005).
110. E.M. Sevick-Muraca, R. Sharma, J.C. Rasmussen, M.V. Marshall, A. Juliet, J.A. Wendt, H.Q. Pham, E.B. Bonefas, J.P. Houston, L. Sampath, K.E. Adams, D.K. Blanchard, R.E. Fisher, S.B. Chiang, R. Elledge and M.E. Mawad, "Imaging of lymph flow in breast cancer patients after microdose administration of a near infrared fuorophore", Radiology 246, 734 (2008). doi:10.1148/radiol. 2463070962
111. X. Intes, J. Ripoli, Y. Chen, S. Nioka, A.G. Yodh and B. Chance, "In vivo continuous-wave optical breast imaging enhanced with indocyanine green", Med. Phys. 30, 1039 (2003). doi:10.1118/1.1573791 (Pubitemid 36735969)
112. B. Alacam, B. Yazici, X.X. Intes, S. Nioka and B. Chance, "Pharmokinetic-rate images of indocyanine green for breast tumours using near-infrared optical methods", Phys. Med. Biol. 53, 837 (2008). doi:10.1088/0031-9155/53/4/002 (Pubitemid 351238109)
113. X. Yang, E.W. Stein, S. Ashkenazi and L.V. Wang "Nanoparticles for photoacoustic Imaging", WIREs Nanomed. Nanobiotechnol. 1, 360 (2009).
114. A. Agarwal, S.W. Huang, M. O'Donnell, K.C. Day, M. Day, N. Kotov and S. Ashkenazi, "Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging", J. App. Phys. 102, 064701 (2007). doi:10.1063/1.2777127 (Pubitemid 47508995)
115. Q. Zhang, N. Iwakuma, P. Sharma, B.M. Moudgil, C. Wu, J. McNeill, H. Jiang and S.R. Grobmyer, "Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography", Nanotechnology 20, 395102 (2009). doi:10.1088/0957-4484/20/39/395102
116. V. Ntziachristos, "Fluorescence molecular imaging", Annu. Rev. Biomed. Eng. 8, 1 (2006). doi:10.1146/annurev. bioeng.8.061505.095831
117. V. Ntziachristos and B. Chance, "Probing physiology and molecular function using optical imaging: applications to breast cancer", Breast Cancer Res. 3, 41 (2001). doi:10.1186/bcr269 (Pubitemid 32223652)
118. S. Luo, E. Zhang, Y. Su, T. Cheng and C. Shi "A review of NIR dyes in cancer targeting and imaging", Biomaterials 32, 7127 (2011). doi:10.1016/j.biomaterials.2011.06.024
119. F. Leblond, S.C. Davis, P.A. Valdés and B.W. Pogue "Preclinical whole-body fluorescence imaging: Review of instruments, methods and applications", J. Photochem. Photobiol. B 98, 77 (2010). doi:10.1016/j.jphotobiol.2009.11.007
120. J. von Burstin, S. Eser, B. Seidler, A. Meining, M. Bajbouj, J. Mages, R. Lang, A.J. Kind, A.E. Schnieke, R.M. Schmid, G. Schneider and D. Saur, "Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice", Int. J. Cancer 123, 2138 (2008). doi:10.1002/ijc.23780
121. V. Ntziachristos, C.-H. Tung, C. Bremer and R. Weissleder, "Fluorescence molecular tomography resolves protease activity in vivo", Nat. Med. 8, 757 (2002). doi:10.1038/nm729 (Pubitemid 34778731)
122. J. Grimm, D.G. Kirsch, S.D. Windsor, C.F. Bender Kim, P.M. Santiago, V. Ntziachristos, T. Jacks and R. Weissleder "Use of gene expression profling to direct in vivo molecular imaging of lung cancer", Proc. Nat. Acad. Sci. USA 102, 14404 (2005). doi:10.1073/pnas.0503920102 (Pubitemid 41429710)
123. J.L. Kovar, W. Volcheck, E. Sevick-Muraca, M.A. Simpson and D.M. Olive, "Characterization and performance of near infrared 2-deoxyglucose optical imaging agent for mouse cancer models", Anal. Biochem. 384, 254 (2009).
124. S. Suzuki, S. Takasaki, T. Ozaki and Y. Kobayashi "Tissue oxygenation monitor using NIR spatially resolved spectroscopy", Proc. SPIE 3597, 582 (1999). doi:10.1117/12.356862
125. Y. Yamashita, A. Maki and H. Koizumi "Measurement system for noninvasive dynamic optical topography", J. Biomed. Opt. 4, 414 (1999). doi:10.1117/1.429940 (Pubitemid 30526365)
126. N.L. Everdell, A.P. Gibson, I.D.C. Tullis, T. Vaithianathan, J.C. Hebden and D.T. Delpy "A frequency multiplexed near infrared topography system for imaging functional activation in the brain", Rev. Sci. Instrum. 76, 093705 (2005). doi:10.1063/1.2038567 (Pubitemid 41395504)
127. F.E.W. Schmidt, M.E. Fry, E.M.C. Hillman J.C. Hebden and D.T. Delpy "A 32-channel time-resolved instrument for medical optical tomography", Rev. Sci. Instrum. 71, 256 (2000). doi:10.1063/1.1150191
128. R. Choe, S.D. Konecky, A. Corlu, K. Lee, T. Durduran, D.R. Busch, S. Pathak, B.J. Czerniecki, J. Tchou, D.L. Fraker, A. de Michele, B. Chance, S.R. Arridge, M. Schweiger, J.P. Culver, M.D. Schnall, M.E. Putt, M.A. Rosen and A.G. Yodh, "Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography", J. Biomed. Optics 14, 024020 (2009). doi:10.1117/1.3103325
129. X. Intes, "Time-Domain Optical Mammography SoftScan®: initial results", Acad. Radiol. 12, 934 (2005). doi:10.1016/j.acra.2005.05.006 (Pubitemid 41116410)
130. S. van de Ven, S. Elias, A. Wiethoff, M. van der Voort, A. Leproux, T. Nielsen, B. Brendel, L. Bakker, M. van der Mark, W. Mali and P. Luijten, "Diffuse optical tomography of the breast: initial validation in benign cysts", Mol. Imaging Biol. 11, 64 (2009). doi:10.1007/s11307-008-0176-x
131. T.O. McBride, B.W. Pogue, S. Jiang, U.L. Osterberg and K.D. Paulsen "A parallel-detection frequency-domain near-infrared tomography system for hemoglobin imaging of the breast in vivo", Rev. Sci. Instrum. 72, 1817 (2001). (Pubitemid 32326217)
132. T.H. Pham, O. Coquoz, J.B. Fishkin, E. Anderson, and B.J. Tromberg "Broad bandwidth frequency domain instrument for quantitative tissue optical spectroscopy", Rev. Sci. Instrum. 71, 2500 (2000). doi:10.1063/1.1150665
133. Q. Zhu, S. Tannenbaum and S.H. Kurtzman "Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring", Surg. Oncol. Clin. N. Am. 16, 307. (2007). doi:10.1016/j.soc.2007.03.008 (Pubitemid 46874223)
134. Y. Ueda, K. Yoshimoto, E. Ohmae, T. Suzuki. T. Yamanaka, D. Yamashita, H. Ogura, C. Teruya, H. Nasu, E. Imi, H. Sakahara, M. Oda and Y. Yamashita "Timeresolved optical mammography and its preliminary clinical results", TCRT 10, 393 (2011).
135. C. Li, H. Zhao, B. Anderson and H. Jiang "Multispectral breast imaging using a ten-wavelength, 64× 64source/detector channels silicon photodiode-based diffuse optical tomography system", Med. Phys. 33, 627 (2006). doi:10.1118/1.2171508
136. B.J. Tromberg, A. Cerussi, S. Shah, M. Compton, A. Durkin, D. Hsiang, J. Butler and R. Mehta, "Diffuse optics in breast cancer: detecting tumors in premenopausal women and monitoring neoadjuvant chemotherapy", Breast Cancer Res. 7, 279 (2005). doi:10.1186/bcr1358 (Pubitemid 41830168)
137. B.J. Tromberg, J.A. Butler et al, "ACRIN 6691 monitoring and predicting breast cancer neoadjuvant chemotherapy response using diffuse optical spectroscopic imaging (DOSI)", J. Clin. Oncol. 29, (abstr TPS249) (2011).
138. J.H.M. Schellens, H.L. McLeod and D.R. Newell (Eds), Cancer Clinical Pharmacology. OUP, Oxford, UK (2005).
139. US Food and Drug Administration, "FDA begins process to remove breast cancer indication from Avastin label", Press release (2010).
140. J. di Masi, R. Hansen and H. Grabowski, "The price of innovation: new estimates of drug development costs", J. Health Econ. 22, 151 (2003) doi: 10.1016/S0167-6296 (02) 00126-1